title: Reply to the letter to the editor 'potential clinical relevant drug-drug interactions: comparison between different compendia, do we have a validated method?' by Conde-Estévez et al.
authors.affiliation: Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam. Electronic address: r.w.f.vanleeuwen@erasmusmc.nl.
authors.forename: R W F
authors.initials: RWF
authors.lastname: van Leeuwen
authors.affiliation: Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam.
authors.forename: R H J
authors.initials: RHJ
authors.lastname: Mathijssen
authors.affiliation: Department of Clinical Pharmacy, Deventer Hospital, Deventer, and University Groningen, Groningen.
authors.forename: F G A
authors.initials: FGA
authors.lastname: Jansman
authors.affiliation: Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
authors.forename: T
authors.initials: T
authors.lastname: van Gelder
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D054539:Medication Therapy Management; D009369:Neoplasms / Q000188:drug therapy*; D010607:Pharmacy Service, Hospital; D019338:Polypharmacy
chemical_list: D000970:Antineoplastic Agents